Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of lactoflavin ester derivative for preparing medicine for treating diabetes mellitus and complication thereof

A technology for riboflavin and diabetes, which is applied in the field of riboflavin ester derivatives for the preparation of drugs for treating diabetes and its complications, can solve the problem of limited storage capacity, and achieve a simple method and high yield Effect

Inactive Publication Date: 2009-11-25
崔福贵
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, taking it alone has only a 15% absorption rate, and the amount of riboflavin stored in the organism is not much, and the excess is excreted in the urine

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of lactoflavin ester derivative for preparing medicine for treating diabetes mellitus and complication thereof
  • Application of lactoflavin ester derivative for preparing medicine for treating diabetes mellitus and complication thereof
  • Application of lactoflavin ester derivative for preparing medicine for treating diabetes mellitus and complication thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Embodiment 1: the preparation of riboflavin laurate

[0019] Weigh 28.8g of riboflavin (purchased from Hubei Guangji Pharmaceutical Co., Ltd., the same below) into a three-necked reaction flask, add 192ml of pyridine, heat to 100°C in an oil bath with stirring, add dropwise 18.6ml of lauroyl chloride and dissolve in 15- After the dropwise addition was completed within 20 minutes, continue to heat up to 118°C and reflux for 1.5 hours, then slowly add 18.6ml of lauroyl chloride dropwise until the reaction solution is transparent, cool and filter, and after the filtrate is concentrated under reduced pressure, add 240ml of methanol to reflux to precipitate crystals. Filtrate and dry at 75°C to obtain 18g of riboflavin laurate with a melting point of 23-245°C, dissolve in 180ml of DMF (dimethylformamide), and use 15×150cm LH 20 Layer column, after 2-3 times of separation and recrystallization, riboflavin-5'-lauric acid monoester, riboflavin-5', 4'-lauric acid diester and rib...

Embodiment 2

[0025] Embodiment 2: the synthesis of riboflavin isobutyrate

[0026] Suspend 5g of riboflavin in 50g of isobutyric anhydride (purchased from ACROS), stir and heat to 40°C, slowly add 6ml of concentrated sulfuric acid dropwise, and continue to stir and react at 50-60°C for 7 hours after the addition, the reaction solution It is transparent, cooled and filtered, the filtrate is poured into ice water and stirred to precipitate precipitates, filtered, washed with water for several times, then heated to dissolve with 40ml of methanol and filtered with a small amount of activated carbon, cooled to crystallize, and refined once with methanol to obtain riboflavin- Tetraisobutyrate. mp 125-128°C. Elemental analysis, calculated value (%) N8.53; measured value N8.32.

Embodiment 3

[0027] Embodiment 3: the preparation of riboflavin-2,6-dimethoxybenzoate

[0028] Weigh 5g of riboflavin and 11g of 2,6-dimethoxybenzoyl chloride (purchased from ACROS), put them into a conical flask, heat and stir at 80-90°C for 1 hour, add 10ml of methanol under cooling, pour into Yellow crystals were precipitated in 2L of water, filtered, washed with water, and dried, yielding about 11.4g of crude product. The crude product was dissolved in 80ml of pyridine and filtered, and the filtrate was poured into 2L of water to precipitate crystals, filtered and dried, and then recrystallized with methanol to obtain riboflavin-2,6-dimethoxybenzoate, mp162-166°C elemental analysis, Calculated (%): C61.58, H5.07, N5.42; found C61.41, H5.24, N5.29.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of an application of a lactoflavin ester derivative and a composition containing the component for preparing a medicine for treating diabetes mellitus and complication thereof. After an accessory material is added into the lactoflavin ester derivative, the mixture can be made into a dosage form of capsules, tablets, granules, injection, and the like. The lactoflavin ester derivative has the functions of promoting the consumption of preadipocyte glucose, activating peroxisome paraphyte activated receptor gamma, reducing the blood sugar of a diabetes mellitus animal model, increasing sensibility on insulin, improving the pancreatic island function and a pancreatic island form and lightening the pathologic change of a diabetic nerve, a diabetic retina, a diabetic kidney and diabetic feet.

Description

technical field [0001] The invention relates to the use of riboflavin ester derivatives for preparing medicines for treating diabetes and its complications. Background technique [0002] Diabetes is a common clinical metabolic disease worldwide. In recent years, with the development of economy and the change of people's diet structure, the prevalence of diabetes is increasing rapidly all over the world. According to statistics, the total number of diabetic patients in the world has reached 190 million, and new diabetic patients have reached 7 million to 8 million people every year. Diabetes has become an epidemic in Asia. It is estimated that there are more than 30 million diabetic patients in my country. Non-insulin dependent type II diabetes accounts for about 90%. According to foreign data, by 2025, there will be more than 250 million diabetic patients in the world, and by 2030, there will be 366 million diabetic patients. It can be seen that diabetes has become anot...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/525A61P3/10
Inventor 崔福贵
Owner 崔福贵
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com